title: Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infection.
abstract: BACKGROUND
  The purpose of this study was to evaluate the impact of inappropriate empiric antimicrobial therapy on the outcome of Pseudomonas aeruginosa bacteraemia according to the primary infection site.
  
  
  METHODS
  A retrospective cohort study including 202 patients with P. aeruginosa bacteraemia was performed. High-risk sites of infection were defined as the lung, intra-abdominal non-hepatobiliary tract or unknown source.
  
  
  RESULTS
  Of the 202 patients with P. aeruginosa bacteraemia, 80 (39.6%) had received inappropriate empiric antimicrobial therapy. No significant difference in the 30-day mortality rate was found between the inappropriate therapy group and the appropriate therapy group (19/80 [23.8%] vs. 32/122 [26.2%], P = 0.692). Patients with pneumonia or non-hepatobiliary tract intra-abdominal infection showed significant association with high mortality, while those with urinary tract or hepatobiliary tract infection showed negative associations with mortality. In the subgroup analysis including 98 patients with high-risk sites of infection, the mortality rate of the inappropriate therapy group was significantly higher than that of the appropriate therapy group (14/26 [53.8%] vs. 23/72 [31.9%], P = 0.035). Inappropriate empiric antimicrobial therapy was also found to be one of the independent risk factors for mortality in patients with high-risk sites of infection (odds ratio [OR] 8.69; 95% confidence interval [CI] 1.86-40.59), along with renal disease, corticosteroid use, polymicrobial infection and higher Pitt bacteraemia score.
  
  
  CONCLUSIONS
  Inappropriate empiric antimicrobial therapy adversely affected the outcome of P. aeruginosa bacteraemia in patients with high-risk sites of infection. Our data suggest that the impact of inappropriate antimicrobial therapy on the outcome of P. aeruginosa bacteraemia may be dependent on the primary site of infection.
authors: Division of Infectious Diseases, Samsung Medical Centre, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea.
authors: E-J
authors: EJ
authors: Joo
authors: C-I
authors: CI
authors: Kang
authors: Y E
authors: YE
authors: Ha
authors: S Y
authors: SY
authors: Park
authors: S-J
authors: SJ
authors: Kang
authors: Y M
authors: YM
authors: Wi
authors: N Y
authors: NY
authors: Lee
authors: D R
authors: DR
authors: Chung
authors: K R
authors: KR
authors: Peck
authors: J-H
authors: JH
authors: Song
references: Antimicrob Agents Chemother. 2007 Mar;51(3):839-44
references: 17194829
references: Ann Intern Med. 2002 Nov 19;137(10):791-7
references: 12435215
references: Arch Intern Med. 1996 Oct 14;156(18):2121-6
references: 8862105
references: Antimicrob Agents Chemother. 2007 Oct;51(10):3510-5
references: 17646415
references: J Hosp Infect. 2002 Sep;52(1):29-36
references: 12372323
references: Clin Infect Dis. 2008 Apr 1;46(7):1121-2; author reply 1122
references: 18444833
references: Infection. 2010 Feb;38(1):25-32
references: 20012908
references: Clin Infect Dis. 2007 Nov 1;45(9):1179-81
references: 17918079
references: Antimicrob Agents Chemother. 2005 Feb;49(2):760-6
references: 15673761
references: Antimicrob Agents Chemother. 2005 Apr;49(4):1306-11
references: 15793102
references: Clin Infect Dis. 2007 Jan 1;44(1):87-93
references: 17143822
references: Clin Infect Dis. 2000 Sep;31 Suppl 4:S131-8
references: 11017862
references: Arch Intern Med. 2005 Feb 14;165(3):308-13
references: 15710794
references: Clin Infect Dis. 2003 Sep 15;37(6):794-9
references: 12955640
references: Ann Intern Med. 1997 Oct 15;127(8 Pt 2):757-63
references: 9382394
references: Ann Intern Med. 2002 Oct 15;137(8):693-5
references: 12379071
references: Microb Drug Resist. 2005 Spring;11(1):68-74
references: 15770098
references: Eur J Clin Microbiol Infect Dis. 2008 Dec;27(12):1219-25
references: 18575908
references: J Antimicrob Chemother. 2009 Mar;63(3):568-74
references: 19126669
references: Clin Infect Dis. 2003 Sep 15;37(6):745-51
references: 12955633
references: Arch Intern Med. 2002 Jan 14;162(1):25-32
references: 11784216
references: Am J Med. 2003 Nov;115(7):529-35
references: 14599631